Low Testosterone in Blaine: How Lite Medical Tests Beyond the Standard Reference Range

By Kyle Kingsley, MD
Medical Director, Lite Medical PLLC

Estimated Reading Time: 8 minutes

What the Standard Reference Range Actually Means

When a commercial lab reports a testosterone reference range of roughly 264–916 ng/dL, that number is not a clinical recommendation — it’s a statistical description. It reflects the distribution of testosterone levels across a broad male population, typically spanning ages 18 to 70+, across different health statuses, different times of day, and different seasonal patterns.

This means a 42-year-old man in peak health who drops from a historically high personal level to the low-300s may still register as “in range” — even if his symptoms are significant and his previous baseline was in the 600s. He isn’t compared to his past self. He’s compared to a population that includes men decades older and in far different health states.

There is also meaningful variability between laboratories. LabCorp and Quest Diagnostics use different assay methods, different calibration standards, and slightly different reference populations. A result that appears borderline at one lab may read differently at another — not because the patient has changed, but because the reference frame has.

The American Urology Association (AUA) and the Endocrine Society both acknowledge that a total testosterone cutoff alone is insufficient for diagnosing hypogonadism. Clinical symptoms must be weighed alongside biochemical values. Many physicians, unfortunately, default to the number without integrating the clinical picture.

The Biology of Testosterone and Why “Normal” Isn’t Always Enough

Testosterone circulates in three forms: roughly 40–50% bound tightly to sex hormone-binding globulin (SHBG), 50–55% loosely bound to albumin, and 1–3% completely free. Only free testosterone and albumin-bound testosterone — together called bioavailable testosterone — are readily available to tissues. SHBG-bound testosterone is essentially inactive.

This matters enormously. A man can have a total testosterone of 480 ng/dL and still experience functional androgen deficiency if his SHBG is significantly elevated. His tissues receive far less active hormone than the total number suggests. Without measuring SHBG and calculating free testosterone, you’re only seeing part of the picture.

SHBG itself fluctuates based on multiple factors:

• Age — SHBG tends to rise as men get older
• Thyroid function — hyperthyroidism elevates SHBG
• Insulin sensitivity — metabolic syndrome and insulin resistance lower SHBG
• Liver health — hepatic dysfunction affects SHBG synthesis
• Certain medications, including some anticonvulsants and estrogens

Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary are also essential to measure. These gonadotropins regulate testicular testosterone production. A man with low testosterone and low LH has a different clinical picture — and different treatment implications — than a man with low testosterone and high LH. One points to central (hypothalamic-pituitary) dysfunction; the other suggests primary testicular failure.

Time of day is another underappreciated variable. Testosterone follows a diurnal rhythm, peaking in the early morning hours and declining through the afternoon. A testosterone drawn at 3:00 PM may be 20–30% lower than the same man’s 8:00 AM value. Standard-of-care testing requires morning collection — and many routine orders don’t specify this.

Symptoms That Signal Androgen Deficiency

Energy and Drive

Persistent fatigue that sleep doesn’t resolve is one of the most common presentations of low testosterone. This isn’t ordinary tiredness — it’s a pervasive flatness in energy that interferes with work performance, exercise motivation, and the simple capacity to engage with the day. Men often describe it as feeling like they’re “running at 60%.”

Cognitive Function

Brain fog, difficulty concentrating, reduced verbal fluency, and slower processing speed are all reported by men with androgen deficiency. Testosterone has direct neurological effects — it supports myelination, neuronal survival, and dopaminergic activity. Some patients notice the cognitive changes before they notice physical symptoms.

Sexual Health

Reduced libido is a hallmark symptom. Many men with low testosterone also experience erectile dysfunction, though ED has multiple contributing causes. Decreased morning erections and reduced sexual thoughts or interest are particularly specific indicators of androgen deficiency.

Body Composition

Testosterone is anabolic — it supports muscle protein synthesis and inhibits fat storage, particularly visceral fat. Men with declining testosterone often notice they’re gaining abdominal fat despite no significant dietary changes, losing muscle despite regular exercise, or struggling to recover adequately from workouts.

Mood and Psychological Wellbeing

Irritability, low-grade depression, reduced motivation, and diminished sense of wellbeing are frequently reported. These changes are subtle at first — friends and family may notice them before the patient does. Testosterone deficiency shares symptom overlap with clinical depression, and the two conditions can co-occur and potentiate one another.

How Lite Medical Tests Beyond the Standard Range

At Lite Medical PLLC, we don’t order a single testosterone level and declare the case closed. Our initial evaluation for men concerned about hormone health includes a comprehensive panel designed to give us a complete picture.

Core hormone panel:

• Total testosterone (morning draw, confirmed with a second sample if borderline)
• Free testosterone (calculated from total testosterone and SHBG, or measured directly by equilibrium dialysis)
• Sex hormone-binding globulin (SHBG)
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
• Estradiol (sensitive assay) — important for both baseline and monitoring on TRT
• Prolactin — to rule out pituitary adenoma, particularly with low LH
• Thyroid panel (TSH, free T3, free T4) — thyroid dysfunction commonly mimics and compounds low testosterone symptoms

Metabolic and health context:

• Complete metabolic panel — liver function, glucose, kidney function
• Fasting lipid panel — cardiovascular risk stratification
• Hemoglobin A1c and fasting insulin — insulin resistance assessment
• CBC with differential — hematocrit is essential before starting TRT and during monitoring
• PSA (men over 40 or at risk) — baseline before initiating testosterone therapy
• DHEA-S — adrenal androgen contribution to overall androgen status

Every lab result is reviewed in the context of a structured symptom assessment. We use validated instruments including the Aging Males’ Symptoms (AMS) scale and the ADAM questionnaire to quantify symptom burden. A man with a total testosterone of 340 ng/dL and significant symptom burden is a different clinical scenario than a man with the same number and no complaints.

We also consider the trajectory. If a patient has historical labs showing testosterone in the 550s three years ago and now presents at 310, that’s a 43% decline — even if 310 is still technically “in range.” That trajectory is clinically meaningful, and we account for it.

What the Research Shows About Testing and Treatment

The clinical literature supports a symptom-integrated approach to testosterone evaluation. The American Urological Association’s 2018 guidelines recommend against using a single testosterone threshold to make treatment decisions, instead emphasizing that diagnosis should combine biochemical results with clinical symptoms and patient context.

The Endocrine Society’s Clinical Practice Guidelines for testosterone deficiency syndrome similarly note that total testosterone cutoffs alone are insufficient, and that free testosterone measurement is particularly important in men with borderline total levels, obesity, or conditions known to alter SHBG.

The Testosterone Trials (TTrials), a coordinated group of seven placebo-controlled trials funded by the NIH, demonstrated that testosterone therapy in symptomatic older men with confirmed low testosterone improved sexual function, physical performance, bone density, and mood outcomes across multiple domains. These findings support a careful, individualized approach to treatment in appropriately selected patients.

More recent data from large observational cohorts have continued to clarify the cardiovascular profile of TRT. The TRAVERSE trial, a major cardiovascular outcomes study, found no increased risk of major adverse cardiovascular events in middle-aged and older men receiving testosterone therapy compared to placebo — an important update to earlier concerns that had led to FDA label changes.

The evidence base continues to evolve, and at Lite Medical PLLC, we apply current guidelines while accounting for each patient’s individual risk profile, comorbidities, and treatment goals.

Myths vs. Facts About Testosterone Testing

Myth: If your testosterone is in the reference range, you don’t have a problem.
Fact: Reference ranges reflect a statistical population distribution, not individual optimization thresholds. Symptomatic men with low-normal testosterone may still benefit from a comprehensive evaluation.

Myth: A single testosterone test is all you need.
Fact: Total testosterone alone misses SHBG-related bioavailability issues, diurnal variation, pituitary-testicular axis function, and the metabolic context that shapes androgen status.

Myth: Low testosterone only affects older men.
Fact: Secondary hypogonadism — often driven by obesity, chronic stress, poor sleep, and metabolic dysfunction — is increasingly common in men in their 30s and 40s.

Myth: You can tell if your testosterone is low by how you feel.
Fact: Symptoms are an important signal, but many overlap with thyroid dysfunction, sleep apnea, depression, and other conditions. Lab evaluation is essential to confirm the diagnosis and rule out other causes.

Myth: Testosterone therapy is only for men with very low levels (under 200 ng/dL).
Fact: Treatment eligibility depends on the combination of symptoms and biochemistry, not a single threshold. The Endocrine Society does not specify a universal cutoff below which treatment is automatically appropriate or above which it is automatically inappropriate.

Myth: Testing for testosterone is the same everywhere.
Fact: Assay methods, collection timing, and interpretation frameworks vary significantly between providers. A comprehensive, physician-directed evaluation produces meaningfully different — and more actionable — results than a routine annual checkup.

Lite Medical’s Clinical Approach in Blaine

Lite Medical PLLC serves men throughout the northern Twin Cities metro, including Blaine and the surrounding communities of Coon Rapids, Fridley, Andover, and Spring Lake Park. Our Blaine clinic, located at 1341 113th Ave NE, Suite 204, is staffed by physicians who specialize in hormone health and metabolic optimization — not generalists who fit testosterone into a 15-minute visit.

Every new patient consultation begins with a structured history and symptom assessment, followed by a comprehensive lab order. We draw blood in the morning to capture peak testosterone levels. Results are reviewed by a physician — not a medical assistant — and discussed in detail with the patient.

We don’t use pre-written protocols. Treatment decisions are individualized based on total testosterone, free testosterone, SHBG, gonadotropins, symptoms, health history, and patient goals. Men with secondary hypogonadism and intact fertility concerns are counseled differently than men with primary testicular failure. Men with metabolic syndrome who may respond to lifestyle optimization are identified and guided accordingly before or alongside hormonal intervention.

If TRT is clinically indicated, we offer multiple delivery modalities — weekly injections, bi-weekly injections, topical formulations — and work with each patient to find the approach that fits their life. Monitoring is structured, not optional: hematocrit, PSA, estradiol, and symptom reassessment at regular intervals.

If you’re a man in Blaine who has been told your testosterone is “normal” but still feels like something is off, a free consultation with Lite Medical PLLC is your next step. We’ll tell you what your labs actually mean — and what your options are.

Related Lite Medical Services

• TRT for Men
• Hormone Optimization
• Medical Weight Loss
• Free Consultation

Related Articles

• Low Testosterone in Minneapolis: Signs, Labs, and When TRT Actually Helps
• Low Testosterone in Eden Prairie: Why Active Men Often Miss the Diagnosis
• Low Testosterone in Woodbury: How Lite Medical Tests for Hypogonadism Beyond Routine Screening
• TRT and Cardiovascular Health: What the TRAVERSE Trial Actually Found
• SHBG Explained: Why Your Total Testosterone Number Isn’t the Whole Story

References

• American Urological Association — Testosterone Deficiency Guideline (2018)
• Endocrine Society — Testosterone Therapy in Men with Hypogonadism (2018)
• PubMed — Testosterone Trials (TTrials): A Coordinated Set of Placebo-Controlled Trials
• PubMed — TRAVERSE Trial: Cardiovascular Safety of Testosterone Replacement Therapy (2023)
• NCBI — Variability in Testosterone Assay Methods and Clinical Implications

Medical Disclaimer

This article is intended for educational purposes only and should not be interpreted as personalized medical advice. Medical decisions should be made in consultation with a licensed healthcare professional who is familiar with your medical history. Treatment plans are individualized, and results vary. Lite Medical PLLC does not provide emergency medical care.

Medication & Regulatory Disclosure

Testosterone replacement therapy (TRT) is a prescription medication. FDA-approved testosterone formulations are available in multiple delivery formats including injectable, topical, and pellet. Some patients may receive compounded testosterone preparations, which are not FDA-approved drug products but are legally prepared by licensed compounding pharmacies. All treatment decisions, including the choice between FDA-approved and compounded formulations, are made by a licensed physician based on individual patient need, clinical assessment, and applicable regulations. Compounded medications are not evaluated by the FDA for safety, efficacy, or quality. Individual results vary.